Cycle Guidelines Tesamorelin Cycle Guidelines Approach Standard Duration 26 weeks Review Point Week 26 imaging Best For Phase III trial exposure pattern Approach Extended Duration 52 weeks Review Point Week 52 imaging Best For Pooled Phase III extension data Approach Long-term (NAFLD context) Duration 12 months Review Point 12-month imaging Best For Liver-fat study exposure pattern Trial data showed visceral fat returns toward baseline after stopping
Biological and therapeutic effects of ortho-silicic acid and some ortho-silicic acid-releasing compounds: New perspectives for therapy
Responsible research protocols always factor this in
Furthermore, because antibodies to sermorelin can develop, if theres any sign that the medication isnt working as expected (for instance, IGF-1 stops rising despite dose increases), the doctor might investigate if neutralizing antibodies are a factor
Samples were separated using a Raptor HILIC-Si 2.1 100 mm, 2.7 m LC column (Restek) with a constant flow rate of 400 l/min following a flow gradient starting at 5% Mobile Phase B (H 2 O + 5 mM AmFm +0.5% formic acid) then going up to 40% in 5 min, which was followed by re-equilibration at 5% B for 4 min and 30s